Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

DXR

Daxor (DXR)

Daxor Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:DXR
日付受信時刻ニュースソース見出しコード企業名
2023/06/2205 : 53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:DXRDaxor Corporation
2023/06/0101 : 54Edgar (US Regulatory)Notification of Late Filing of Monthly Portfolio Investments Report on Form N-port (public) (nt Nport-p)AMEX:DXRDaxor Corporation
2023/05/2619 : 02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:DXRDaxor Corporation
2023/03/1705 : 37Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)AMEX:DXRDaxor Corporation
2023/03/0207 : 13Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)AMEX:DXRDaxor Corporation
2023/01/0505 : 45Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2/a)AMEX:DXRDaxor Corporation
2022/12/0707 : 20Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2)AMEX:DXRDaxor Corporation
2022/11/2601 : 17Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)AMEX:DXRDaxor Corporation
2022/11/2122 : 13Edgar (US Regulatory)Current Report Filing (8-k)AMEX:DXRDaxor Corporation
2022/11/1723 : 01Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)AMEX:DXRDaxor Corporation
2022/11/1507 : 00Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)AMEX:DXRDaxor Corporation
2022/11/1506 : 47Edgar (US Regulatory)Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a)AMEX:DXRDaxor Corporation
2022/09/0919 : 02Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2)AMEX:DXRDaxor Corporation
2022/08/3004 : 47Edgar (US Regulatory)Annual Report of Proxy Voting Record for Management Investment Companies (n-px)AMEX:DXRDaxor Corporation
2022/08/2605 : 07Edgar (US Regulatory)Certified Semi-annual Shareholder Report for Management Investment Companies (n-csrs)AMEX:DXRDaxor Corporation
2022/06/3005 : 07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:DXRDaxor Corporation
2022/06/0106 : 14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:DXRDaxor Corporation
2022/05/2519 : 01Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)AMEX:DXRDaxor Corporation
2022/03/1606 : 27Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)AMEX:DXRDaxor Corporation
2022/03/0107 : 58Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)AMEX:DXRDaxor Corporation
2022/02/0120 : 45Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)AMEX:DXRDaxor Corporation
2022/02/0120 : 42Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:DXRDaxor Corporation
2022/01/2506 : 39Edgar (US Regulatory)Current Report Filing (8-k)AMEX:DXRDaxor Corporation
2022/01/2122 : 00GlobeNewswire Inc.Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of DirectorsAMEX:DXRDaxor Corporation
2022/01/2106 : 05GlobeNewswire Inc.Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022AMEX:DXRDaxor Corporation
2022/01/0622 : 00GlobeNewswire Inc.Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual ConferenceAMEX:DXRDaxor Corporation
2022/01/0522 : 00GlobeNewswire Inc.DAXOR ANNOUNCES KEY MILESTONES ACHIEVED FOR MULTICENTER BVA-100® STUDY IN HOSPITALIZED PATIENTS WITH COVID-19AMEX:DXRDaxor Corporation
2022/01/0422 : 00GlobeNewswire Inc.DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESAMEX:DXRDaxor Corporation
2021/12/1607 : 29Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2)AMEX:DXRDaxor Corporation
2021/12/1607 : 27Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2)AMEX:DXRDaxor Corporation
 Showing the most relevant articles for your search:AMEX:DXR

最近閲覧した銘柄

Delayed Upgrade Clock